Breaking News

SafeBridge Launches Predictive Tox Capabilities

By Kristin Brooks | December 10, 2013

Aims to enable higher throughput and risk prioritization strategies

SafeBridge Consultants, a division of Trinity Consultants, Inc., has launched computational predictive toxicology services to the biopharmaceutical and chemical industry, designed to enable higher throughput and risk prioritization strategies.
SafeBridge is an authorized user of Derek Nexus from Lhasa Ltd., a knowledge-based expert system for the prediction of toxicological hazard, and Leadscope from Leadscope, Inc., a statistical predictive quantitative structure-activity relationships (QSAR) model.
SafeBridge will apply these two software packages to assist companies in meeting the proposed International Conference on Harmonization (ICH) M7 “Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk” guideline; conduct risk assessments of extractable and leachable chemicals into drug products; assess the potential toxicity of contaminants in drugs; and assist in chemical synthetic process development.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.